Viewing Study NCT05795920


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:29 AM
Study NCT ID: NCT05795920
Status: UNKNOWN
Last Update Posted: 2023-04-03
First Post: 2023-03-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Utidelone Injection Combined With Gemcitabine in First-line Chemotherapy for Unresectable Advanced Pancreatic Cancer
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module